Advertisement
Screener

TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) Net Income

TONIX PHARMACEUTICALS HOLDING CORP. Net Income

TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) reported Net Income of -$40.55 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.

Financial Statements › Income Statement › Net Income

us-gaap:NetIncomeLoss · last filed 2026-08-10

  • TONIX PHARMACEUTICALS HOLDING CORP. net income (loss) attributable to parent for the quarter ending 2026-06-30 was -$40.55M.
  • TONIX PHARMACEUTICALS HOLDING CORP. net income (loss) attributable to parent for the quarter ending 2026-03-31 was -$40.19M.
  • TONIX PHARMACEUTICALS HOLDING CORP. net income (loss) attributable to parent for the quarter ending 2025-12-31 was -$46.91M.
  • TONIX PHARMACEUTICALS HOLDING CORP. net income (loss) attributable to parent for the quarter ending 2025-09-30 was -$32.01M.
  • TONIX PHARMACEUTICALS HOLDING CORP. net income (loss) attributable to parent for fiscal 2025 was -$124.02M.
  • TONIX PHARMACEUTICALS HOLDING CORP. net income (loss) attributable to parent for fiscal 2024 was -$130.04M.
  • TONIX PHARMACEUTICALS HOLDING CORP. net income (loss) attributable to parent for fiscal 2023 was -$116.66M.
  • TONIX PHARMACEUTICALS HOLDING CORP. net income (loss) attributable to parent for fiscal 2022 was -$110.22M.
Period endNet Income (Loss) Attributable to Parent 3 monthNet Income (Loss) Attributable to Parent 3 month as first filedNet Income (Loss) Attributable to Parent 6 monthNet Income (Loss) Attributable to Parent 6 month as first filedNet Income (Loss) Attributable to Parent 7 monthNet Income (Loss) Attributable to Parent 7 month as first filedNet Income (Loss) Attributable to Parent 9 monthNet Income (Loss) Attributable to Parent 9 month as first filedNet Income (Loss) Attributable to Parent 12 monthNet Income (Loss) Attributable to Parent 12 month as first filedNet Income (Loss) Attributable to Parent 43 monthNet Income (Loss) Attributable to Parent 46 monthNet Income (Loss) Attributable to Parent 55 monthNet Income (Loss) Attributable to Parent 58 monthNet Income (Loss) Attributable to Parent 61 monthNet Income (Loss) Attributable to Parent 64 monthNet Income (Loss) Attributable to Parent 67 monthNet Income (Loss) Attributable to Parent 70 monthNet Income (Loss) Attributable to Parent 73 monthNet Income (Loss) Attributable to Parent 76 monthNet Income (Loss) Attributable to Parent 79 monthNet Income (Loss) Attributable to Parent 82 month
2026-06-30-$40.55M
10-Q · filed 2026-08-10
-$80.75M
10-Q · filed 2026-08-10
-$127.66M
derived: sum of 3 quarters · filed 2026-08-10
-$159.67M
derived: sum of 4 quarters · filed 2026-08-10
2026-03-31-$40.19M
10-Q · filed 2026-08-10
-$87.10M
derived: sum of 2 quarters · filed 2026-08-10
-$119.11M
derived: sum of 3 quarters · filed 2026-08-10
-$147.39M
derived: sum of 4 quarters · filed 2026-08-10
2025-12-31-$46.91M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12
-$78.92M
derived: sum of 2 quarters · filed 2026-03-12
-$107.19M
derived: sum of 3 quarters · filed 2026-08-10
-$124.02M
10-K · filed 2026-03-12
2025-09-30-$32.01M
10-Q · filed 2025-11-10
-$60.28M
derived: sum of 2 quarters · filed 2026-08-10
-$77.11M
10-Q · filed 2025-11-10
-$99.22M
derived: sum of 4 quarters · filed 2026-08-10
2025-06-30-$28.27M
10-Q · filed 2026-08-10
-$45.10M
10-Q · filed 2026-08-10
-$67.21M
derived: sum of 3 quarters · filed 2026-08-10
-$81.42M
derived: sum of 4 quarters · filed 2026-08-10
2025-03-31-$16.83M
10-Q · filed 2026-08-10
-$38.94M
derived: sum of 2 quarters · filed 2026-08-10
-$53.15M
derived: sum of 3 quarters · filed 2026-08-10
-$131.93M
derived: sum of 4 quarters · filed 2026-08-10
2024-12-31-$22.11M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12
-$36.32M
derived: sum of 2 quarters · filed 2026-03-12
-$115.10M
derived: sum of 3 quarters · filed 2026-03-12
-$130.04M
10-K · filed 2026-03-12
2024-09-30-$14.21M
10-Q · filed 2025-11-10
-$92.99M
derived: sum of 2 quarters · filed 2025-11-10
-$107.93M
10-Q · filed 2025-11-10
-$135.25M
derived: sum of 4 quarters · filed 2025-11-10
2024-06-30-$78.78M
10-Q · filed 2025-11-10
-$93.72M
10-Q · filed 2025-08-11
-$121.04M
derived: sum of 3 quarters · filed 2025-11-10
-$149.01M
derived: sum of 4 quarters · filed 2025-11-10
2024-03-31-$14.94M
10-Q · filed 2025-11-10
-$42.26M
derived: sum of 2 quarters · filed 2025-11-10
-$70.24M
derived: sum of 3 quarters · filed 2025-11-10
-$98.59M
derived: sum of 4 quarters · filed 2025-11-10
2023-12-31-$27.32M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18
-$55.30M
derived: sum of 2 quarters · filed 2025-03-18
-$83.65M
derived: sum of 3 quarters · filed 2025-03-18
-$116.66M
10-K · filed 2025-03-18
2023-09-30-$27.98M
10-Q · filed 2024-11-12
-$56.33M
derived: sum of 2 quarters · filed 2024-11-12
-$89.34M
10-Q · filed 2024-11-12
-$121.02M
derived: sum of 4 quarters · filed 2024-11-12
2023-06-30-$28.36M
10-Q · filed 2024-11-12
-$61.36M
10-Q · filed 2024-08-16
-$93.04M
derived: sum of 3 quarters · filed 2024-11-12
-$122.02M
derived: sum of 4 quarters · filed 2024-11-12
2023-03-31-$33.01M
10-Q · filed 2024-11-12
-$64.69M
derived: sum of 2 quarters · filed 2024-11-12
-$93.67M
derived: sum of 3 quarters · filed 2024-11-12
-$116.81M
derived: sum of 4 quarters · filed 2024-11-12
2022-12-31-$31.68M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01
-$60.66M
derived: sum of 2 quarters · filed 2024-04-01
-$83.80M
derived: sum of 3 quarters · filed 2024-04-01
-$110.22M
10-K · filed 2024-04-01
2022-09-30-$28.98M
10-Q · filed 2023-11-09
-$52.12M
derived: sum of 2 quarters · filed 2023-11-09
-$78.54M
10-Q · filed 2023-11-09
-$108.09M
derived: sum of 4 quarters · filed 2023-11-09
2022-06-30-$23.14M
10-Q · filed 2023-11-09
-$49.56M
10-Q · filed 2023-08-10
-$79.11M
derived: sum of 3 quarters · filed 2023-11-09
-$97.64M
derived: sum of 4 quarters · filed 2023-11-09
2022-03-31-$26.42M
10-Q · filed 2023-11-09
-$55.97M
derived: sum of 2 quarters · filed 2023-11-09
-$74.50M
derived: sum of 3 quarters · filed 2023-11-09
-$98.05M
derived: sum of 4 quarters · filed 2023-11-09
2021-12-31-$29.55M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13
-$48.08M
derived: sum of 2 quarters · filed 2023-03-13
-$71.63M
derived: sum of 3 quarters · filed 2023-03-13
-$92.29M
10-K · filed 2023-03-13
2021-09-30-$18.53M
10-Q · filed 2022-11-07
-$42.08M
derived: sum of 2 quarters · filed 2022-11-07
-$62.73M
10-Q · filed 2022-11-07
-$79.75M
derived: sum of 4 quarters · filed 2022-11-07
2021-06-30-$23.55M
10-Q · filed 2022-11-07
-$44.21M
10-Q · filed 2022-08-08
-$61.23M
derived: sum of 3 quarters · filed 2022-11-07
-$73.22M
derived: sum of 4 quarters · filed 2022-11-07
2021-03-31-$20.65M
10-Q · filed 2022-11-07
-$37.67M
derived: sum of 2 quarters · filed 2022-11-07
-$49.66M
derived: sum of 3 quarters · filed 2022-11-07
-$63.84M
derived: sum of 4 quarters · filed 2022-11-07
2020-12-31-$17.02M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-14
-$29.01M
derived: sum of 2 quarters · filed 2022-03-14
-$43.19M
derived: sum of 3 quarters · filed 2022-03-14
-$50.46M
10-K · filed 2022-03-14
2020-09-30-$11.99M
10-Q · filed 2021-11-08
-$26.17M
derived: sum of 2 quarters · filed 2021-11-08
-$33.44M
10-Q · filed 2021-11-08
-$42.15M
derived: sum of 4 quarters · filed 2021-11-08
2020-06-30-$14.18M
10-Q · filed 2021-11-08
-$21.45M
10-Q · filed 2021-08-09
-$30.16M
derived: sum of 3 quarters · filed 2021-11-08
-$38.00M
derived: sum of 4 quarters · filed 2021-11-08
2020-03-31-$7.27M
10-Q · filed 2021-11-08
-$15.98M
derived: sum of 2 quarters · filed 2021-11-08
-$23.82M
derived: sum of 3 quarters · filed 2021-11-08
-$29.66M
derived: sum of 4 quarters · filed 2021-11-08
2019-12-31-$8.71M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15
-$16.55M
derived: sum of 2 quarters · filed 2021-03-15
-$22.39M
derived: sum of 3 quarters · filed 2021-03-15
-$28.62M
10-K · filed 2021-03-15
2019-09-30-$7.84M
10-Q · filed 2020-11-09
-$13.68M
derived: sum of 2 quarters · filed 2020-11-09
-$19.91M
10-Q · filed 2020-11-09
-$27.50M
derived: sum of 4 quarters · filed 2020-11-09
2019-06-30-$5.84M
10-Q · filed 2020-11-09
-$12.07M
10-Q · filed 2020-08-10
-$19.66M
derived: sum of 3 quarters · filed 2020-11-09
-$25.14M
derived: sum of 4 quarters · filed 2020-11-09
2019-03-31-$6.23M
10-Q · filed 2020-11-09
-$13.82M
derived: sum of 2 quarters · filed 2020-11-09
-$19.30M
derived: sum of 3 quarters · filed 2020-11-09
-$25.39M
derived: sum of 4 quarters · filed 2020-11-09
2018-12-31-$7.59M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-24
-$13.07M
derived: sum of 2 quarters · filed 2020-03-24
-$19.15M
derived: sum of 3 quarters · filed 2020-03-24
-$26.09M
10-K · filed 2020-03-24
2018-09-30-$5.48M
10-Q · filed 2019-11-08
-$11.57M
derived: sum of 2 quarters · filed 2019-11-08
-$18.50M
10-Q · filed 2019-11-08
-$23.99M
derived: sum of 4 quarters · filed 2019-11-08
2018-06-30-$6.09M
10-Q · filed 2019-11-08
-$13.02M
10-Q · filed 2019-08-12
-$18.52M
derived: sum of 3 quarters · filed 2019-11-08
-$24.30M
derived: sum of 4 quarters · filed 2019-11-08
2018-03-31-$6.93M
10-Q · filed 2019-11-08
-$12.43M
derived: sum of 2 quarters · filed 2019-11-08
-$18.21M
derived: sum of 3 quarters · filed 2019-11-08
-$22.99M
derived: sum of 4 quarters · filed 2019-11-08
2017-12-31-$5.49M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18
-$11.28M
derived: sum of 2 quarters · filed 2019-03-18
-$16.06M
derived: sum of 3 quarters · filed 2019-03-18
-$21.12M
10-K · filed 2019-03-18
2017-09-30-$5.79M
10-Q · filed 2018-11-09
-$10.57M
derived: sum of 2 quarters · filed 2018-11-09
-$15.63M
10-Q · filed 2018-11-09
-$23.11M
derived: sum of 4 quarters · filed 2018-11-09
2017-06-30-$4.78M
10-Q · filed 2018-08-13
-$9.84M
10-Q · filed 2018-08-13
-$17.33M
derived: sum of 3 quarters · filed 2018-08-13
-$24.90M
derived: sum of 4 quarters · filed 2018-08-13
2017-03-31-$5.06M
10-Q · filed 2018-05-11
-$12.55M
derived: sum of 2 quarters · filed 2018-05-11
-$20.12M
derived: sum of 3 quarters · filed 2018-05-11
-$29.93M
derived: sum of 4 quarters · filed 2018-05-11
2016-12-31-$7.48M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09
-$15.06M
derived: sum of 2 quarters · filed 2018-03-09
-$24.87M
derived: sum of 3 quarters · filed 2018-03-09
-$38.84M
10-K · filed 2018-03-09
2016-09-30-$7.58M
10-Q · filed 2017-11-06
-$17.38M
derived: sum of 2 quarters · filed 2017-11-06
-$31.36M
10-Q · filed 2017-11-06
-$44.72M
derived: sum of 4 quarters · filed 2017-11-06
2016-06-30-$9.81M
10-Q · filed 2017-08-11
-$23.78M
10-Q · filed 2017-08-11
-$37.14M
derived: sum of 3 quarters · filed 2017-08-11
-$50.39M
derived: sum of 4 quarters · filed 2017-08-11
2016-03-31-$13.98M
10-Q · filed 2017-05-12
-$27.34M
derived: sum of 2 quarters · filed 2017-05-12
-$40.59M
derived: sum of 3 quarters · filed 2017-05-12
-$52.35M
derived: sum of 4 quarters · filed 2017-05-12
2015-12-31-$13.36M
10-K · filed 2016-03-03
-$26.61M
derived: sum of 2 quarters · filed 2016-11-10
-$38.37M
derived: sum of 3 quarters · filed 2016-11-10
-$48.05M
10-K · filed 2017-04-13
2015-09-30-$13.25M
10-Q · filed 2016-11-10
-$25.01M
derived: sum of 2 quarters · filed 2016-11-10
-$34.69M
10-Q · filed 2016-11-10
-$43.68M
derived: sum of 4 quarters · filed 2016-11-10
2015-06-30-$11.76M
10-Q · filed 2016-08-05
-$21.44M
10-Q · filed 2016-08-05
-$30.43M
derived: sum of 3 quarters · filed 2016-08-05
-$37.85M
derived: sum of 4 quarters · filed 2016-08-05
2015-03-31-$9.68M
10-Q · filed 2016-05-06
-$18.67M
derived: sum of 2 quarters · filed 2016-05-06
-$26.09M
derived: sum of 3 quarters · filed 2016-05-06
-$32.13M
derived: sum of 4 quarters · filed 2016-05-06
2014-12-31-$8.99M
10-K · filed 2016-03-03
-$16.41M
derived: sum of 2 quarters · filed 2016-03-03
-$22.45M
derived: sum of 3 quarters · filed 2016-03-03
-$27.62M
10-K · filed 2016-03-03
2014-09-30-$7.42M
10-K · filed 2016-03-03
-$13.46M
derived: sum of 2 quarters · filed 2016-03-03
-$18.63M
10-Q · filed 2015-11-06
-$22.33M
derived: sum of 4 quarters · filed 2016-03-03
2014-06-30-$6.04M
10-K · filed 2016-03-03
-$11.21M
10-Q · filed 2015-08-07
-$14.91M
derived: sum of 3 quarters · filed 2016-03-03
-$18.00M
derived: sum of 4 quarters · filed 2016-03-03
2014-03-31-$5.16M
10-K · filed 2016-03-03
-$8.87M
derived: sum of 2 quarters · filed 2016-03-03
-$11.96M
derived: sum of 3 quarters · filed 2016-03-03
-$14.05M
derived: sum of 4 quarters · filed 2016-03-03
-$31.89M
10-Q · filed 2014-05-13
2013-12-31-$3.71M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-03
-$6.80M
derived: sum of 2 quarters · filed 2016-03-03
-$8.88M
derived: sum of 3 quarters · filed 2016-03-03
-$10.88M
10-K · filed 2016-03-03
-$26.73M
10-K · filed 2014-03-28
2013-09-30-$3.09M
10-Q · filed 2014-11-07
-$5.18M
derived: sum of 2 quarters · filed 2014-11-07
-$7.18M
10-Q · filed 2014-11-07
-$7.18M
10-Q · filed 2013-11-13
-$9.81M
derived: sum of 4 quarters · filed 2014-11-07
-$23.02M
10-Q · filed 2013-11-13
2013-06-30-$2.09M
10-Q · filed 2014-08-08
-$2.09M
10-Q · filed 2013-08-14
-$4.09M
10-Q · filed 2014-08-08
-$4.09M
10-Q · filed 2013-08-14
-$6.72M
derived: sum of 3 quarters · filed 2014-08-08
-$8.45M
derived: sum of 4 quarters · filed 2014-08-08
-$19.93M
10-Q · filed 2013-08-14
2013-03-31-$2.00M
10-Q · filed 2014-05-13
-$2.00M
10-Q · filed 2013-05-07
-$4.63M
derived: sum of 2 quarters · filed 2014-05-13
-$6.36M
derived: sum of 3 quarters · filed 2014-05-13
-$8.09M
derived: sum of 4 quarters · filed 2014-05-13
-$17.85M
10-Q · filed 2013-05-07
2012-12-31-$2.63M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28
-$4.36M
derived: sum of 2 quarters · filed 2014-03-28
-$6.09M
derived: sum of 3 quarters · filed 2014-03-28
-$9.45M
10-K · filed 2014-03-28
-$9.45M
10-K · filed 2013-03-11
-$15.84M
10-K/A · filed 2013-11-22
2012-09-30-$1.73M
10-Q · filed 2012-11-14
-$3.46M
derived: sum of 2 quarters · filed 2013-11-13
-$6.82M
10-Q · filed 2013-11-13
-$7.07M
derived: sum of 4 quarters · filed 2014-03-28
-$13.22M
10-Q · filed 2012-11-14
2012-06-30-$1.73M
10-Q · filed 2013-11-13
-$3.07M
10-Q · filed 2012-08-13
-$5.09M
10-Q · filed 2013-08-14
-$5.33M
derived: sum of 3 quarters · filed 2014-03-28
-$6.35M
derived: sum of 4 quarters · filed 2014-03-28
-$11.48M
10-Q · filed 2012-08-13
2012-03-31-$2.01M
10-Q · filed 2013-05-07
-$3.60M
derived: sum of 2 quarters · filed 2014-03-28
-$4.62M
derived: sum of 3 quarters · filed 2014-03-28
-$4.97M
derived: sum of 4 quarters · filed 2014-03-28
-$8.41M
10-Q · filed 2012-05-15
2011-12-31-$1.59M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28
-$2.60M
derived: sum of 2 quarters · filed 2014-03-28
-$2.96M
derived: sum of 3 quarters · filed 2014-03-28
-$3.47M
10-K · filed 2014-03-28
-$3.47M
10-K · filed 2012-03-30
-$6.39M
10-K · filed 2012-03-30
2011-09-30-$1.01M
10-Q · filed 2012-11-14
-$2.32K
10-Q · filed 2011-10-07
-$1.37M
derived: sum of 2 quarters · filed 2012-11-14
-$1.88M
10-Q · filed 2012-11-14
-$9.35K
10-Q · filed 2011-10-07
-$3.84M
derived: sum of 4 quarters · filed 2014-03-28
-$80.03K
10-Q · filed 2011-10-07
2011-06-30-$355.81K
10-Q · filed 2012-08-13
-$1.52K
10-Q · filed 2011-08-15
-$869.47K
10-Q · filed 2012-08-13
-$7.03K
10-Q · filed 2011-08-15
-$2.82M
derived: sum of 3 quarters · filed 2014-03-28
-$2.83M
derived: sum of 4 quarters · filed 2014-03-28
-$77.71K
10-Q · filed 2011-08-15
2011-03-31-$513.66K
10-Q · filed 2012-05-15
-$2.47M
derived: sum of 2 quarters · filed 2014-03-28
-$2.47M
derived: sum of 3 quarters · filed 2014-03-28
-$2.47M
derived: sum of 4 quarters · filed 2014-03-28
2010-12-31-$1.95M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28
-$1.96M
derived: sum of 2 quarters · filed 2014-03-28
-$1.96M
derived: sum of 3 quarters · filed 2014-03-28
-$1.96M
10-K · filed 2014-03-28
-$1.96M
10-K · filed 2012-03-30
2010-09-30-$3.69K
10-Q · filed 2011-10-07
-$6.09K
derived: sum of 2 quarters · filed 2011-10-07
-$11.91K
10-Q · filed 2011-10-07
2010-06-30-$2.40K
10-Q · filed 2011-08-15
-$8.22K
10-Q · filed 2011-08-15
2009-12-31-$221.00K
10-K · filed 2014-03-28
-$220.83K
10-K · filed 2012-03-30
2008-12-31-$202.00K
10-K · filed 2014-03-28
-$202.26K
10-K · filed 2012-03-30
2007-12-31-$537.00K
10-K · filed 2014-03-28
-$537.00K
10-K · filed 2013-03-11

Similar stocks

Stock NameCountryMarket CapPE Ratio
Minerva Neurosciences, Inc. (NERV)United States$0.165B-0.66
ADC Therapeutics SA (ADCT)$0.163B-1.39
LIFECORE BIOMEDICAL, INC. DE (LFCR)United States$0.163B-8.50
Organogenesis Holdings Inc. (ORGO)United States$0.182B-3.70
AN2 Therapeutics, Inc. (ANTX)United States$0.185B-4.84
Annexon, Inc. (ANNX)United States$0.147B-4.22
PepGen Inc. (PEPG)United States$0.186B-1.73
Corbus Pharmaceuticals Holdings, Inc. (CRBP)United States$0.144B-1.72
ALX ONCOLOGY HOLDINGS INC (ALXO)United States$0.187B-3.52
Fortress Biotech, Inc. (FBIO)United States$0.188B0.91